2m 2m 2m 2m 2m 2m 2m
Nordisk Sp ADR-B (NVO)
NYSE
$47.23+$1.35 (+2.94%)
Price as of Jun 23, 2026 5:06 PM EDT- $153.8BMarket Cap
- -31.13%1-Year Change
- Drug Manufacturers - GeneralIndustry
Nordisk Sp ADR-B (NVO)
$47.23+$1.35 (+2.94%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 309.1B +6.43% | 290.4B +25.03% | 232.3B +31.26% | 177.0B +25.68% | |
Cost of Revenue | 58.8B +32.04% | 44.5B +24.48% | 35.8B +25.72% | 28.4B +20.25% | |
Gross Profit | 250.3B +1.79% | 245.9B +25.13% | 196.5B +32.32% | 148.5B +26.77% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -52.0B +8.27% | -48.1B +48.14% | -32.4B +34.91% | -24.0B +35.31% | |
Depreciation and Amortization Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Operating Expenses | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Profit | 127.7B -0.53% | 128.3B +25.12% | 102.6B +37.11% | 74.8B +27.56% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -4.2B +156.52% | -1.6B +202.58% | -542.0M +43.39% | -378.0M +30.80% | |
Interest Income and Expense and Net | -4.2B +156.52% | -1.6B +202.58% | -542.0M +43.39% | -378.0M +30.80% | |
Total Nonoperating Income and Expense | 4.2B +156.52% | 1.6B +202.58% | 542.0M +43.39% | 378.0M +30.80% | |
Income before Taxes | 102.4B +1.43% | 101.0B +20.68% | 83.7B +50.71% | 55.5B +16.27% | |
Income Taxes | 28.1B +7.26% | 26.2B +24.83% | 21.0B +55.06% | 13.5B +19.55% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 102.4B +1.43% | 101.0B +20.68% | 83.7B +50.71% | 55.5B +16.27% | |
Net Income from Continuing Operations Applicable to Common | 102.4B +1.43% | 101.0B +20.68% | 83.7B +50.71% | 55.5B +16.27% | |
Basic EPS and Net Income | 23.06 +1.72% | 22.67 +21.42% | 18.67 -23.83% | 24.51 +17.89% | |
Diluted EPS and Net Income | 23.03 +1.77% | 22.63 +21.54% | 18.62 -23.81% | 24.44 +17.84% | |
Basic Weighted Average Shares | 4.4B -0.24% | 4.5B -0.64% | 4.5B +97.89% | 2.3B -1.36% | |
Diluted Weighted Average Shares | 4.4B -0.24% | 4.5B -0.64% | 4.5B +97.89% | 2.3B -1.36% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 26.5B +69.05% | 15.7B +8.78% | 14.4B +13.74% | 12.7B +18.04% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 26.5B +69.05% | 15.7B +8.78% | 14.4B +13.74% | 12.7B +18.04% | |
Total Current Assets | 172.5B +7.18% | 160.9B +15.22% | 139.6B +29.07% | 108.2B +26.40% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | N/A N/A | N/A N/A | 91.0B +36.43% | 66.7B +20.43% | |
Total Long-Term Assets | 370.4B +21.50% | 304.9B +74.39% | 174.8B +31.40% | 133.1B +22.17% | |
Total Assets | 542.9B +16.55% | 465.8B +48.11% | 314.5B +30.35% | 241.3B +24.03% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 52.0M -99.60% | 13.1B +102.42% | 6.5B +341.88% | 1.5B -94.48% | |
Total Current Liabilities | 215.7B -0.86% | 217.5B +28.22% | 169.7B +40.28% | 120.9B +21.53% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 133.2B +27.12% | 104.8B +173.79% | 38.3B +3.91% | 36.8B +51.91% | |
Total Liabilities | 348.9B +8.24% | 322.3B +55.01% | 207.9B +31.79% | 157.8B +27.48% | |
Retained Earnings | 195.3B +35.20% | 144.4B +37.78% | 104.8B +30.09% | 80.6B +11.92% | |
Total Stockholders Equity | 194.0B +35.24% | 143.5B +34.65% | 106.6B +27.64% | 83.5B +18.01% | |
Total Shares Outstanding | 1.1B -75.79% | 4.4B -1.53% | 4.5B +97.81% | 2.3B -1.30% | |
Cash Flow | |||||
Cash from Operating Activities | 119.1B -1.54% | 121.0B +11.07% | 108.9B +38.06% | 78.9B +43.43% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -79.2B -38.59% | -128.9B +193.66% | -43.9B +76.15% | -24.9B -21.16% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -28.4B -425.22% | 8.7B +113.83% | -63.2B +21.93% | -51.8B +103.18% | |
Financials Ratio | |||||
Gross Margin | 80.98% -4.36% | 84.67% +0.08% | 84.60% +0.81% | 83.92% N/A | |
Operating Margin | 41.30% -6.54% | 44.19% +0.07% | 44.16% +4.46% | 42.28% N/A | |
Return on Assets | 20.31% -21.54% | 25.89% -14.05% | 30.12% +18.18% | 25.48% N/A | |
Return on Equity | 60.70% -24.86% | 80.78% -8.28% | 88.07% +22.31% | 72.00% N/A | |
Revenue Growth | 6.43% -74.33% | 25.03% -19.91% | 31.26% +21.72% | 25.68% N/A | |
Current Ratio | 0.80 +8.10% | 0.74 -10.13% | 0.82 -7.99% | 0.89 N/A | |
Cash Ratio | 0.12 +70.42% | 0.07 -15.09% | 0.08 -18.93% | 0.10 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow